Equities

Select Medical Holdings Corp

Select Medical Holdings Corp

Actions
Health CareHealth Care Providers
  • Price (USD)34.01
  • Today's Change-0.23 / -0.67%
  • Shares traded663.94k
  • 1 Year change+19.17%
  • Beta1.4419
Data delayed at least 15 minutes, as of May 23 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Select Medical Holdings Corporation operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers. Its segments include critical illness recovery hospital, rehabilitation hospital, outpatient rehabilitation, and Concentra. The critical illness recovery hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. Its Concentra segment consists of occupational health centers that provide workers’ compensation injury care, physical therapy, and consumer health services and onsite clinics located at employer worksites that deliver occupational health services.

  • Revenue in USD (TTM)6.79bn
  • Net income in USD259.99m
  • Incorporated2004
  • Employees38.40k
  • Location
    Select Medical Holdings CorpC/O Select Medical Corp4714 Gettysburg RdMECHANICSBURG 17055United StatesUSA
  • Phone+1 (717) 972-1100
  • Fax+1 (302) 655-5049
  • Websitehttps://www.selectmedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Agilon Health Inc4.78bn-207.85m2.28bn1.12k--3.31--0.477-0.5182-0.7111.781.682.13--3.714,283,411.00-9.27---20.91--6.37---4.35------0.0514--80.74---112.01------
Progyny Inc1.11bn61.26m2.61bn563.0045.234.6241.042.360.60710.607110.985.951.53--3.631,968,529.008.4811.5011.8816.0221.8921.485.536.64----0.000.0038.3459.52104.35--44.47--
Evolent Health Inc2.18bn-141.23m2.67bn4.70k--2.51--1.23-1.25-1.2519.2810.720.8316--6.30462,948.70-4.22-9.60-5.36-12.5920.5624.50-5.07-13.66---0.05480.3272--45.2625.65-660.71---6.18--
Quidelortho Corp2.86bn-1.76bn2.77bn7.10k--0.8351--0.9674-26.38-26.3842.8249.520.36962.678.92403,197.20-22.7911.34-25.5712.9148.1362.71-61.6520.930.8070.87860.42070.00-8.2141.83-101.84--45.87--
Irhythm Technologies Inc513.17m-129.96m2.85bn2.00k--31.51--5.55-4.22-4.2216.712.900.770910.857.37256,587.00-19.52-21.92-22.55-26.7766.9669.39-25.33-25.756.95-18.440.877--19.9027.32-6.24--50.82--
Lifestance Health Group Inc1.10bn-173.12m2.86bn6.87k--2.00--2.59-0.4671-0.46712.973.740.5175--7.50118,339.20-8.12---8.93-------15.69-----4.690.1652--22.82--13.59------
Amedisys Inc2.25bn-20.59m3.14bn19.00k--2.891,034.161.40-0.6446-0.644668.7333.301.12--6.89118,495.10-1.057.82-1.3810.3944.3943.63-0.94395.89--11.620.25610.000.5936.11-108.22--14.16--
Surgery Partners Inc2.79bn600.00k3.23bn10.50k8,355.261.6411.681.160.0030.00322.1415.480.410424.895.90266,142.802.331.173.201.6333.7326.335.673.031.562.470.4606--8.039.1478.21--17.41--
Radnet Inc1.66bn21.27m4.30bn7.87k179.264.9323.972.600.32480.324824.8311.810.6159--7.88210,591.101.861.242.391.6621.9321.563.021.86--1.730.43650.0013.0510.64-71.42-37.6319.60--
Select Medical Holdings Corp6.79bn259.99m4.45bn38.40k16.413.218.210.65592.092.0954.6210.650.8726--6.37176,767.904.264.195.265.4614.4413.984.895.11--3.780.697815.305.225.5753.0311.986.50--
CorVel Corp773.52m74.97m4.73bn4.44k64.0720.2546.896.114.324.3244.5313.661.81--8.82174,059.6017.5814.2931.3822.8922.0122.059.698.78----0.000.0011.195.17-0.067815.28-1.01--
Option Care Health Inc4.43bn272.67m5.06bn5.81k19.163.5415.121.141.521.5224.808.221.3914.009.15763,044.908.553.6310.644.3522.3522.456.152.781.396.980.42640.009.0643.4277.40--24.72--
Acadia Healthcare Company Inc2.99bn-11.30m6.06bn23.50k--2.0945.362.03-0.1354-0.135432.7131.300.5667--8.17176,030.70-0.06532.32-0.07262.64-----0.11535.601.255.860.3843--12.208.99-107.93--3.34--
Data as of May 23 2024. Currency figures normalised to Select Medical Holdings Corp's reporting currency: US Dollar USD

Institutional shareholders

53.29%Per cent of shares held by top holders
HolderShares% Held
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 202416.67m12.99%
BlackRock Fund Advisorsas of 31 Mar 202415.36m11.97%
The Vanguard Group, Inc.as of 31 Mar 202412.69m9.89%
T. Rowe Price Investment Management, Inc.as of 31 Mar 20245.66m4.41%
Dimensional Fund Advisors LPas of 31 Mar 20244.40m3.43%
SSgA Funds Management, Inc.as of 31 Mar 20244.15m3.24%
Camber Capital Management LPas of 31 Mar 20243.40m2.65%
Geode Capital Management LLCas of 31 Mar 20242.26m1.76%
Principal Global Investors LLCas of 31 Mar 20242.24m1.75%
Charles Schwab Investment Management, Inc.as of 31 Mar 20241.56m1.21%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.